Angiotensin converting enzyme inhibitors (original) (raw)

vascular protection Emerging role of angiotensin-converting enzyme inhibitors in cardiac and

2010

Could the Pharmacological Differences Observed Between Angiotensin II Antagonists and Inhibitors of Angiotensin Converting Enzyme be Clinically Beneficial?

Marc de Gasparo

Pharmacology & Toxicology, 1992

View PDFchevron_right

Maximally Recommended Doses of Angiotensin-Converting Enzyme (ACE) Inhibitors Do Not Completely Prevent ACE-Mediated Formation of Angiotensin II in Chronic Heart Failure

Jay Lisker

Circulation, 2000

View PDFchevron_right

Non-Corresponding Effects of an Angiotensin-Converting Enzyme Inhibitor on Cardiac and Vascular Hypertrophy in Spontaneously Hypertensive Rats

Hiromi Muratani

Hypertension Research, 2000

View PDFchevron_right

Pleiotropic benefits and utility of angiotensin converting enzyme inhibitors in current practice

Vishal Chaudhari

International Journal of Research in Medical Sciences, 2021

View PDFchevron_right

Effects of ACE Inhibitors on Cardiac Angiotensin II and Aldosterone in Humans: “Relevance of Lipophilicity and Affinity for ACE”

Ross Davies

American Journal of Hypertension, 2010

View PDFchevron_right

Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications

Thomas Unger

Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001

View PDFchevron_right

Angiotensin-converting enzyme inhibition to enhance vascular health--clinical and research models

George Bakris

American journal of hypertension, 2001

View PDFchevron_right

The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death

Vu Chu

View PDFchevron_right

Ischemic heart disease: the next target for the angiotensin-converting enzyme inhibitors

Eva Lonn

ACE in Ischemic Heart Disease

View PDFchevron_right

Angiotensin converting enzyme inhibitors in the treatment of hypertension

Govindasamy Mugesh

2011

View PDFchevron_right

ACE-inhibitors and atherosclerosis

Ettore Ambrosioni

European Journal of Epidemiology, 1992

View PDFchevron_right

Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators

Hendrik Buikema

Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy, 2000

View PDFchevron_right

Angiotensin II receptor blockade and end-organ protection

Thomas Unger

American Journal of Hypertension, 1999

View PDFchevron_right

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

Michael Domanski

New England Journal of Medicine, 2004

View PDFchevron_right

Lonn, E. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis. Curr. Atheroscler. Rep. 4, 363-372

Eva Lonn

Current Atherosclerosis Reports

View PDFchevron_right

Protective effect of long-term angiotensin II inhibition

Leon Ferder

AJP: Heart and Circulatory Physiology, 2007

View PDFchevron_right

Possible Role of Angiotensin-Converting Enzyme 2 and Activation of Angiotensin II Type 2 Receptor by Angiotensin-(1–7) in Improvement of Vascular Remodeling by Angiotensin II Type 1 Receptor Blockade

Nour Abdullah

Hypertension, 2014

View PDFchevron_right

Angiotensin II-Receptor Blockers: Current Role in Clinical Practice

Emmanuel Andreadis

2010

View PDFchevron_right

Angiotensin converting enzyme inhibitors for cancer treatment?

Benny Jensen

Acta Oncologica, 2004

View PDFchevron_right

Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence

C.A. Dézsi

View PDFchevron_right

Angiotensin-Converting Enzyme Independent Contraction to Angiotensin I in Human Resistance Arteries

Neal Padmanabhan

Circulation, 1999

View PDFchevron_right

Angiotensins and the Heart

Daniel Batlle

Hypertension, 2015

View PDFchevron_right

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

Walther Ferreira

2010

View PDFchevron_right

Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

Ibrahim Haznedaroğlu

Medical Hypotheses, 2002

View PDFchevron_right

Effects of angiotensin converting enzyme inhibition in patients with stable coronary artery disease: The prevention of events with angiotensin converting enzyme inhibition (PEACE) trial: the PEACE Study investigators

Leon Ferder

Circulation

View PDFchevron_right

Comparative effects of ACE inhibition and angiotensin II receptor blockade in the prevention of renal damage

Jeremiah Morrissey

Kidney International, 2002

View PDFchevron_right

Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating …

Amanda McBroom

2010

View PDFchevron_right

Modulating atherosclerosis through inhibition or blockade of angiotensin

Robert Rosenson

Clinical Cardiology, 2003

View PDFchevron_right

Influence of angiotensin-converting enzyme inhibition on cardiac function in myocardial infarction

Alexis Rump

The American Journal of Cardiology, 1990

View PDFchevron_right

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition

Andrea Daragó

PLoS ONE, 2014

View PDFchevron_right

Angiotensin converting enzyme inhibitors (original) (raw)

Related papers